MINE YOUR MIND
Confounding Factors in Treatment-Resistant Depression (Part 2): Comorbidities and Treatment Resistance
by Michael I. Casher, MD, Daniel Gih, MD, Joshua D. Bess, MD,
and Prachi Agarwala, MD |
August 3, 2012
Dr Casher is Director, Psychiatry Adult Inpatient Program, and Clinical Assistant Professor, department of psychiatry, University of Michigan Medical School, Ann Arbor. Dr Gih is Clinical Assistant Professor, Attending, Child and Adolescent Inpatient Psychiatry, University of Michigan Medical School. Dr Bess is Clinical Instructor, At-tending, Adult Inpatient Psychiatry, University of Michigan Medical School. Dr Agarwala is Child and Ado-lescent Psychiatry Hospitalist, Fairview Health Services, Minneapolis. Drs Casher and Bess are co-authors of Manual of Inpatient Psychiatry (Cambridge University Press, 2010), reviewed in Psychiatric Times, February 2011. Dr Casher reports that he is on the Speakers Bureau for Sunovion Pharmaceuticals and AstraZeneca. Drs Casher and Bess receive royalties from Cambridge University Press. Drs Gih, Bess, and Agarwala report no conflicts concerning the subject matter of this article.
7. What percentage of patients with MDD also have a breathing-related sleep condition?
8. Clinicians who treat elderly patients with depression and associated anxiety should be alert for all but one of the following:
A. Poorer response to treatment
B. High rate of treatment drop-out
C. Increased rates of recurrence of illness
D. Increased rates of delusional thinking